Detection of hepatitis B virus variants in HBV monoinfected and HBV/HIV coinfected Iranian patients under lamivudine treatment

Chronic hepatitis B affects nearly 10% of HIV-infected patients. Hepatitis B virus (HBV) infection is a dynamic disease and coinfection with HIV impacts directly on the outcome of HBV infection, considerably complicating its natural history, diagnosis, and management. The aim of this study was to compare two cohorts of HBV monoinfected and HBV/HIV coinfected Iranian patients undergoing long-term lamivudine therapy from the clinical and virological aspects, as well as the frequency of detected mutations in HBV genome. To this end, HBV Pol/S regions from 72 patients were PCR-amplified and directly sequenced. Phylogenetic analysis indicated a 40-times higher risk of coinfection with ayw3 subtype of HBV genotype D rather than ayw2 subtype [P<0.001, odd: 40.66, CI: 95 % (4.69-352.23)]. While no resistance mutation was detected in HBV/HIV coinfected cohort, LAM-resistance mutations (rtM204I/V in YMDD and rtL180M in FLLA polymerase motifs) were identified in 30% (9 out of 30) and 16.66% (5 out of 30) of HBV monoinfected patients (P<0.05). Moreover, several mutations (sP105A, sI110S/L, sS136Y and sP127T/L) with significant differences in the frequency were identified in the S region of both cohorts. Finally, this study found strong correlation between the type of infection (mono or coinfection) and characteristics like patient gender, ALT levels, HBV-DNA levels and HBV subtypes. These results pointed to the importance of determination of HBV variants in the management of patients and suggested that in contrary to HBV monoinfections, LAM may be still an appropriate drug for the treatment of HBV in HBV/HIV coinfected patients; however, further studies to clarify the role of HIV in HBV LAM-resistance mutations are required.     

Comparison of serum enzyme activity in great sturgeon, Huso huso, cultured in brackish and freshwater earth ponds in Iran

Blood samples were collected from 60 great sturgeons, Huso huso, to establish the following serum enzyme activity: aspartate amino-transferase (AST), alanine amino-transferase (ALT), lactic acid dehydrogenase (LDH), creatine kinase (CK), and alkaline phosphatase (ALP) using an autoanalyzer, and acid phosphatase (ACP) by manual method. Thirty 5-year-old cultured fish were caught from each of two sites; a brackish-water earth pond in Bafgh and a freshwater pond in Gorgan in the centre and northeast of Iran, during May 2006. Results of the serum enzymes activity for H. huso samples from Bafgh and Gorgan were: AST, 502.9 ± 258.2 and 436.1 ± 186.8; ALT, 104.4 ± 35.1 and 53.1 ± 38.7; LDH, 3094.2 ± 1277.5 and 2486.3 ± 1393.3; CK, 3632.9 ± 2618.7 and 3967 ± 5054.9; ALP, 281.2 ± 112.7 and 762.2 ± 600.2; ACP, 13.3 ± 2.5 and 33 ± 6.8 IU/L. Mean values of ALT, ALP and ACP were significantly different in the fish from the two sites (p < 0.05). These results may be used to understand some biological (e.g., serum enzyme activity) and ecological characteristics of cultured H. huso.     

Comparing GnRH agonist long protocol and gnrh antagonist protocol in outcome the first cycle of ART

Purpose  

This prospective study evaluated the efficacy of gonadotropin-releasing hormone (GnRH) antagonist protocol in comparison with the GnRH agonist protocol in the first cycle of assisted reproductive technique (ART).     

Simulated ABO and Rh blood typing

BACKGROUND: Blood typing historically has been used to introduce students to the concepts of immunohematology. Risk of disease transmission has compelled school districts to prohibit the use of human blood in student laboratories. A method is needed that will safely simulate ABO and Rh typing. STUDY DESIGN AND METHODS: A method that uses inorganic salt solutions to simulate ABO and Rh antigens and antibodies was studied. Additional salt solutions and diluents were tested to investigate the feasibility of simulating both ABO and Rh typing in a more realistic medium. RESULTS: Cobalt nitrate and sodium hydroxide were found to successfully simulate D and anti-D, respectively. The addition of these solutions did not produce cross- reactions in ABO tests. Use of simulated blood as a diluent improved the appearance of the samples. CONCLUSION: This method can safely and inexpensively simulate ABO and Rh blood typing procedures and provide students with hands-on blood-typing experience.     

Current autologous transfusion practices. Implications for the future

A questionnaire was distributed to 509 AABB institutional members to evaluate current autologous transfusion practices. Results were returned from 47 blood centers, 108 transfusion services and 64 hospital blood banks (response rate 43%). Results indicate that not all eligible patients are allowed to donate due to unnecessarily strict eligibility criteria. Thirty percent of autologous units are not tested for infectious disease markers. Of those units tested and found positive for anti-HIV or HBsAg, 53 and 72% respectively, of the institutions provide the units to the intended recipient. Forty-seven percent of institutions perform an AHG crossmatch for autologous recipients. Sixty five percent of institutions permit "crossing-over" of autologous units for homologous use. Implications of these findings for the development of standards for autologous transfusion programs are discussed.